UNC119B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.567000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.664000E-01
Normal-vs-Stage2
7.862100E-02
Normal-vs-Stage3
6.058500E-02
Normal-vs-Stage4
1.164830E-01
Stage1-vs-Stage2
1.181370E-01
Stage1-vs-Stage3
1.134620E-01
Stage1-vs-Stage4
1.690590E-01
Stage2-vs-Stage3
4.129800E-01
Stage2-vs-Stage4
9.162000E-01
Stage3-vs-Stage4
5.493200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.093000E-01
Normal-vs-AfricanAmerican
5.066800E-01
Normal-vs-Asian
7.303800E-03
Caucasian-vs-AfricanAmerican
8.425000E-01
Caucasian-vs-Asian
4.377400E-03
AfricanAmerican-vs-Asian
4.899600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.940800E-01
Normal-vs-Female
4.204600E-01
Male-vs-Female
9.999400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.536400E-01
Normal-vs-Age(41-60Yrs)
6.171800E-01
Normal-vs-Age(61-80Yrs)
3.704600E-01
Normal-vs-Age(81-100Yrs)
3.354200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.522400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.455800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.584400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.868200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.561600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.546400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.051920E-02
Normal-vs-Daily Drinker
1.547000E-01
Normal-vs-Weekly Drinker
1.411690E-02
Normal-vs-Occasional Drinker
7.280200E-01
Normal-vs-Social Drinker
8.758600E-01
Non Drinker-vs-Daily Drinker
4.518400E-01
Non Drinker-vs-Weekly Drinker
9.496400E-01
Non Drinker-vs-Occasional Drinker
4.503900E-02
Non Drinker-vs-Social Drinker
1.007180E-01
Daily Drinker-vs-Weekly Drinker
5.635400E-01
Daily Drinker-vs-Occasional Drinker
1.422960E-01
Daily Drinker-vs-Social Drinker
2.078400E-01
Weekly Drinker-vs-Occasional Drinker
5.645900E-02
Weekly Drinker-vs-Social Drinker
1.111040E-01
Occasional Drinker-vs-Social Drinker
8.363400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.851800E-01
Normal-vs-Grade 2
6.110800E-01
Normal-vs-Grade 3
5.604000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.642000E-02
Grade 1-vs-Grade 3
5.756400E-02
Grade 1-vs-Grade 4
4.851800E-01
Grade 2-vs-Grade 3
5.519200E-01
Grade 2-vs-Grade 4
6.110800E-01
Grade 3-vs-Grade 4
5.604000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.000300E-02
Normal-vs-NonDiabetic
5.163600E-01
Diabetic-vs-NonDiabetic
9.028100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.510200E-02
Normal-vs-NoPancreatitis
4.552600E-01
Pancreatitis-vs-NoPancreatitis
1.654230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.058800E-01
Normal-vs-N1
9.017800E-02
N0-vs-N1
1.315360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.614400E-02
Normal-vs-TP53-NonMutant
8.996400E-01
TP53-Mutant-vs-TP53-NonMutant
4.616500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
